|
Sept. 28, 2017 |
|
|
April. 09, 2022 |
|
|
jRCT1092220311 |
Ophthalmologic approach for the sleep apnea syndrome (Ophthalmologic approach for SAS) |
|
Ophthalmologic approach for the sleep apnea syndrome |
YOSHIAKI ICHIBE |
||
Kanagawa Dental University Graduare School |
||
Tsuruya-cyo 3-31-6, Kanagawa-ku.Yokohama Kanagawa. JAPAN |
||
+81-45-313-4036 |
||
ichibe@kdu.ac.jp |
||
YOSHIAKI ICHIBE |
||
Kanagawa Dental University Graduate School |
||
Tsuruya-cyo 3-31-6, Kanagawa-ku.Yokohama Kanagawa. JAPAN |
||
+81-45-313-4036 |
||
ichibe@kdu.ac.jp |
PENDING |
Dec. 01, 2017 |
||
| 30 | ||
Interventional |
||
open label, single arm |
||
open(masking not used) |
||
No |
||
N/A |
||
Patients who were diagnosed as sleep apnea syndrome and obtained consent to eye examination |
||
Age under than 20 years |
||
| 20age old over | ||
| No limit | ||
Both |
||
sleep apnea syndrome |
||
Intervention type:DEVICE Name of intervention:CPAP(Continuous Positive Air Pressure) Dose form / Japanese Medical Device Nomenclature:DEVICE Continuous Positive Air Pressure treatment Route of administration / Site of application:TRANSTRACHEAL Dose per administration: Dosing frequency / Frequency of use:QD Planned duration of intervention:use it during sleeping for 6months Intended dose regimen:using every evening detailes of teratment arms:Patients with sleep apnea syndrome undergoing Continuous Positive Air Pressure treatment group. Comparative intervention name: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use: Planned duration of intervention: Intended dose regimen: |
||
Does the treatment influence ocular tension? (increase,decrease,or no influence) |
||
Prevalence of patients with Glaucoma in the SAS. |
||
| Kanagawa Dental University Graduate School | |
| Kanagawa Dental University Graduate School |
| Research Ethics Review Committee of Kanagawa Dental University | |
| No | |
| Under review |
| JMA-IIA00311 | |
| Japan |